Summary & Overview
HCPCS Q0084: Chemotherapy Infusion Administration, Per Visit
HCPCS Level II code Q0084 denotes chemotherapy administration by infusion technique only, billed per visit. This code captures the professional or facility service of delivering chemotherapy via infusion when the drug supply is billed separately. As chemotherapy delivery is a high-cost, high-frequency service across oncology care settings nationally, accurate use of Q0084 affects claims processing, revenue recognition, and quality measurement for infusion services.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, common billing practices, and payer coverage considerations. The publication summarizes typical sites of service for infusion administration and highlights where Q0084 is commonly applied relative to drug administration billing.
The report provides benchmarks and comparisons for coverage policies, outlines common modifiers associated with infusion visit billing (listed separately), and reviews implications for claims documentation. It also summarizes policy updates relevant to chemotherapy infusion billing and practical coding considerations for clinicians, coders, and revenue cycle staff. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code Q0084 describes chemotherapy administration by infusion technique only, per visit. This service represents the administration of chemotherapeutic agents via an infusion method without inclusion of the drug product itself.
-
Service type: Chemotherapy administration by infusion
-
Typical site of service: Infusion center or outpatient clinic visit
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with metastatic colorectal cancer presents to an outpatient oncology infusion center for a scheduled chemotherapy infusion visit. The patient arrives after pre-visit nursing assessment confirms current laboratory values acceptable for treatment, intravenous access is established (peripheral IV or implanted port), and antiemetic prophylaxis is given per protocol. The chemotherapy infusion agent was prepared by pharmacy and the visit includes only infusion administration services (no concurrent infusion pump management beyond standard administration, no separate evaluation and management service related to chemotherapy decision-making). The billing for this encounter is reported using Q0084 to indicate chemotherapy administration by infusion technique only, per visit. Typical workflow steps: initial nursing triage and vitals; verification of orders and consent; venous access assessment and catheter flushing; administration of the chemotherapeutic infusion with medication and infusion time documented; post-infusion observation and discharge instructions. Typical site of service is an outpatient infusion center or hospital outpatient department where intravenous chemotherapy is administered.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no modifier applies and payer requires explicit reporting (rare). |